Lactate and lactylation in breast cancer: current understanding and therapeutic opportunities
Breast cancer (BC) has the highest prevalence among cancers specific to women, and its incidence rates are increasing in many countries. Subtypes of BC, including HER2-positive or triple-negative BC, exhibit differing treatment responses; consequently, demand for personalized therapy is increasing,...
Saved in:
Main Authors: | Lan Huang, Xuemei Chen, Meina Yan, Ze Xiang, Jian Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2025-07-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | https://www.cancerbiomed.org/content/22/7/789 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lactate and lactylation: emerging roles in autoimmune diseases and metabolic reprogramming
by: Wenjun Liu, et al.
Published: (2025-06-01) -
Lactate Metabolism and Lactylation Modification: New Opportunities and Challenges in Cardiovascular Disease
by: Mengyang Song, et al.
Published: (2025-07-01) -
Lactylation: From Molecular Insights to Disease Relevance
by: Yao Xu, et al.
Published: (2025-06-01) -
Research progress on the interaction between glucose metabolic reprogramming and lactylation in tumors
by: Yi Yang, et al.
Published: (2025-07-01) -
Epigenetic Modulation by Lactylation in Sepsis: Linking Metabolism to Immune Dysfunction
by: Chen Y, et al.
Published: (2025-06-01)